First Time Loading...

Vera Therapeutics Inc
NASDAQ:VERA

Watchlist Manager
Vera Therapeutics Inc Logo
Vera Therapeutics Inc
NASDAQ:VERA
Watchlist
Price: 41.39 USD -1.31% Market Closed
Updated: May 20, 2024

EV/EBITDA
Enterprise Value to EBITDA

-15.4
Current
-5.3
Median
4.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-15.4
=
Enterprise Value
1.6B
/
EBITDA
-101.9m
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
-12.8
2-Years Forward
EV/EBITDA
-10.6
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More